Regeneron Sues Celltrion For Proposed Biosimilar of Eylea in West Virginia District Court
Formycon and Celltrion Announce FDA Submission of aBLAs Seeking Approval to Market Aflibercept Biosimilars
Regeneron Files Expedited Motion Challenging Mylan’s Designation of Entire aBLA Production as Outside Counsel’s Eyes Only
Regeneron Files First BPCIA Complaint Regarding Biosimilar Eylea against Mylan in West Virginia District Court
CA Gov. Newsom Announces Budget Approval for Biosimilar Insulin Initiative
Subscribe: Subscribe via RSS
Blogs
Firm/Org